14 Geographic Atrophy Clinical Trials in Palo Alto, CA (2026)

Q: How do I join a clinical trial in Palo Alto?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you.

Recruiting Geographic Atrophy Studies in Palo Alto

NCT03126916Recruiting

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

This phase III trial studies iobenguane I-131 or lorlatinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or ganglioneuroblastoma. Radioactive drugs, s...

Palo Alto, CAPHASE3750 participantsChildren's Oncology Group

View Study Details

NCT03827694Recruiting

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

This study will establish a non-invasive diagnostic approach and evaluate clinical outcomes for children at high-risk for pulmonary invasive fungal infection (PIFI)....

Palo Alto, CA400 participantsArkansas Children's Hospital Research Institute

View Study Details

NCT06679855Recruiting

Milrinone for Prevention of Post-ligation Cardiac Syndrome Trial

The goal of this Phase 3, randomized, masked clinical trial is to is to find out whether milrinone, when given to infants after PDA closure, will help the heart work better by supplying oxygen to the ...

Palo Alto, CAPHASE3316 participantsNICHD Neonatal Research Network

View Study Details

NCT05219617Recruiting

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults

The primary objective is to evaluate the efficacy of carisbamate (YKP509) as adjunctive treatment in reducing the number of drop seizures (tonic, atonic, and tonic-clonic) compared with placebo in ped...

Palo Alto, CAPHASE3252 participantsSK Life Science, Inc.

View Study Details

NCT06655246Recruiting

A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)

In this clinical trial, the safety, tolerability, and preliminary antitumor activity of ziftomenib in combination with imatinib will be evaluated in adults with gastrointestinal stromal tumors (GIST) ...

Palo Alto, CAPHASE1157 participantsKura Oncology, Inc.

View Study Details

NCT07647328Recruiting

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

The purpose of this study is to investigate the efficacy, safety, and tolerability of camizestrant in combination with ribociclib in patients with ER+ HER2- BC who have not received any other systemic...

Palo Alto, CAPHASE3150 participantsAstraZeneca

View Study Details

NCT07001748Recruiting

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

This study is being done to answer the following questions: Can we lower the chance of your gastric cancer from growing or spreading by administering paclitaxel chemotherapy directly into your abdomi...

Palo Alto, CAPHASE2148 participantsECOG-ACRIN Cancer Research Group

View Study Details

NCT07425574Recruiting

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

Macular dystrophies are a group of inherited eye conditions that affect the macula. The macula is in the center of the retina, the light sensitive part at the back of the eye. In people with macular d...

Palo Alto, CA90 participantsAstellas Pharma Global Development, Inc.

View Study Details

NCT07282587Recruiting

Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma

This is a two-stage Phase 2 trial evaluating the efficacy and safety of ONC206 in participants with Pheochromocytoma and Paraganglioma (PCPG)....

Palo Alto, CAPHASE290 participantsJazz Pharmaceuticals

View Study Details

NCT07199465Recruiting

A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)

Researchers are looking for a way to prevent cytomegalovirus (CMV) in children and adolescents who receive a kidney transplant (KT) and weigh less than 40 kilograms (88.2 pounds). The goals of the stu...

Palo Alto, CAPHASE140 participantsMerck Sharp & Dohme LLC

View Study Details

NCT07024563Recruiting

Study of Ravulizumab in Pediatric Participants With Primary IgAN

The primary objectives of this study are to characterize ravulizumab pharmacokinetics (PK) and pharmacodynamics (PD), and to evaluate safety and efficacy following ravulizumab IV dosing in pediatric p...

Palo Alto, CAPHASE336 participantsAlexion Pharmaceuticals, Inc.

View Study Details

NCT05274048Recruiting

Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients

This is Phase 1 dose finding trial with potential dose expansion to evaluate the safety, toxicity, recommended phase 2 dose (RP2D), and maximum tolerated dose (MTD) of Neratinib plus TDxD using a stan...

Palo Alto, CAPHASE118 participantsFox Chase Cancer Center

View Study Details

NCT07594236Recruiting

Phase 1 Study of C.001 in Retinal Degeneration

This is a first-in-human Phase 1 study evaluating the safety and tolerability of C.001 in patients with retinal diseases involving degeneration of the retinal pigment epithelium. Participants will re...

Palo Alto, CAPHASE115 participantsCellio Therapeutics Inc

View Study Details

NCT07609303Recruiting

Feeding the Flame, One Day at a Time: Design and Acceptability of a Serious Game to Support Medication Adherence and Education for Pediatric Solid Organ Transplant Patients

Children and teenagers who receive a solid organ transplant (such as a kidney, liver, or heart) must take medications every day to keep their new organ healthy. Taking these medications correctly and ...

Palo Alto, CANA15 participantsStanford University

View Study Details

About Geographic Atrophy Clinical Trials in Palo Alto

Geographic atrophy is the advanced form of dry age-related macular degeneration, involving progressive loss of retinal cells. It leads to enlarging blind spots in central vision. Recently approved complement inhibitor therapies can slow progression.

There are currently 14 geographic atrophy clinical trials recruiting participants in Palo Alto, CA. These studies are seeking a combined 2,477 participants. Research is being sponsored by Children's Oncology Group, Arkansas Children's Hospital Research Institute, NICHD Neonatal Research Network and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Geographic Atrophy Clinical Trials in Palo Alto — FAQ

Are there geographic atrophy clinical trials in Palo Alto?

Yes, there are 14 geographic atrophy clinical trials currently recruiting in Palo Alto, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Palo Alto?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Palo Alto research site will contact you about next steps.

Are clinical trials in Palo Alto free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Palo Alto studies also compensate for your time and travel.

What geographic atrophy treatments are being tested?

The 14 active trials in Palo Alto are testing new therapies including novel drugs, biologics, and treatment approaches for geographic atrophy.

Data updated October 16, 2026 from ClinicalTrials.gov